 Bringing a new world of vision to cataract patients (with and without presbyopia), Visiogen is expected to revolutionize the field of cataract surgery by offering the first 3-dimensional, single-piece, dual optic accommodating intraocular lens (IOL).
 Embodying a major paradigm shift in intraocular lens implants, the Synchrony® IOL is developed with two
separate optics connected by a spring system. The device’s unique design may overcome the limitations of
monovision and single-optic accommodating IOLs.
  The U.S. Food and Drug Administration (FDA) has not approved SynchronyŽ for commercial use. The Synchrony dual optic accommodating IOL is an investigational device in the United States. |
  The Synchrony lens is designed to expand and contract naturally within the eye. This may allow patients to see well at all focal points without glasses or contacts. Learn more
   |